Federal Register / Vol. 72, No. 44 / Wednesday, March 7, 2007 / Notices 10227 

ESTIMATES OF ANNUALIZED HOUR BURDEN

Form Number of 

respondents 

Responses 

per 

respondents 

Total 

responses 

Hours per 

response 

Total burden 

hours 

Deceased Donor Registration .............................................. 58 215 12,470 0.4200 5,237.4000 

Death referral data ............................................................... 58 12 696 10.0000 6,960.0000 

Living Donor Registration .................................................... 711 10 7,110 0.4100 2,915.1000 

Living Donor Follow-up ........................................................ 711 18 12,798 0.3300 4,223.3400 

Donor Histocompatibility ...................................................... 154 95 14,630 0.0600 877.8000 

Recipient Histocompatibility ................................................. 154 172 26,488 0.1100 2,913.6800 

Heart Candidate Registration .............................................. 135 23 3,105 0.2800 869.4000 

Lung Candidate Registration ............................................... 67 27 1,809 0.2800 506.5200 

Heart/Lung Candidate Registration ..................................... 59 1 59 0.2800 16.5200 

Thoracic Registration ........................................................... 135 27 3,645 0.4400 1,603.8000 

Thoracic Follow-up ............................................................... 135 229 30,915 0.4130 12,767.8950 

Kidney Candidate Registration ............................................ 250 133 33,250 0.2800 9,310.0000 

Kidney Registration .............................................................. 250 69 17,250 0.4400 7,590.0000 

Kidney Follow-up ................................................................. 250 544 136,000 0.3332 45,315.2000 

Liver Candidate Registration ............................................... 125 89 11,125 0.2800 3,115.0000 

Liver Registration ................................................................. 125 54 6,750 0.4000 2,700.0000 

Liver Follow-up ..................................................................... 125 383 47,875 0.3336 15,971.1000 

Kidney/Pancreas Candidate Registration ............................ 146 12 1,752 0.2800 490.5600 

Kidney/Pancreas Registration .............................................. 146 7 1,022 0.5300 541.6600 

Kidney/Pancreas Follow-up ................................................. 146 65 9,490 0.5027 4,770.6230 

Pancreas Candidate Registration ........................................ 146 7 1,022 0.2800 286.1600 

Pancreas Registration .......................................................... 146 3 438 0.4400 192.7200 

Pancreas Follow-up ............................................................. 146 23 3,358 0.4133 1,387.8614 

Intestine Candidate Registration .......................................... 45 8 360 0.2400 86.4000 

Intestine Registration ........................................................... 45 4 180 0.5300 95.4000 

Intestine Follow-up ............................................................... 45 17 765 0.5059 387.0135 

Post Transplant Malignancy ................................................ 711 6 4,266 0.0800 341.2800 

Total .............................................................................. 923 ........................ 388,628 ........................ 131,472.4329 

Send comments to Susan G. Queen, 

PhD, HRSA Reports Clearance Officer, 

Room 10–33, Parklawn Building, 5600 

Fishers Lane, Rockville, MD 20857. 

Written comments should be received 

within 60 days of this notice. 

Dated: February 27, 2007. 

Alexandra Huttinger, 

Acting Director, Division of Policy Review 

and Coordination. 

[FR Doc. E7–3918 Filed 3–6–07; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

National Practitioner Data Bank; 

Announcement of Proactive Disclosure 

Service (PDS) Opening Date and User 

Fees 

AGENCY: Health Resources and Services 

Administration, HHS. 

ACTION: Notice. 

SUMMARY: The Health Resources and 

Services Administration (HRSA), 

Department of Health and Human 

Services (HHS), is announcing the 

implementation of a Proactive 

Disclosure Service (PDS) Prototype. The 

PDS is being offered as an alternative to 

the periodic querying of the National 

Practitioner Data Bank (NPDB). It was 

developed in response to the growing 

interest of healthcare entities in ongoing monitoring of practitioner 

credentials. 

Authorized Data Bank entities can 

choose to enroll all of their practitioners 

in PDS or enroll some practitioners 

while continuing to periodically query 

on others using the regular query 

methods. The query fee for periodic 

queries remains $4.75 per name. Entities 

with PDS enrolled practitioners will be 

notified within one business day of the 

NPDB’s receipt of a report on any of 

their enrollees. While entities can 

expect to receive reports sooner with 

PDS, the format of and the information 

contained in a report, as well as the 

information required to be reported will 

remain the same. Initially, the PDS is 

being offered as a prototype. The annual 

subscription fee, during the prototype 

period, is $3.25 per practitioner. This 

rate is subject to change after the 

prototype period is complete. 

DATES: This fee will be effective April 

30, 2007. 

FOR FURTHER INFORMATION CONTACT: 

Mark Pincus, Branch Chief, Practitioner 

Data Banks Branch, Office of Workforce 

Evaluation and Quality Assurance, 

Bureau of Health Professions, Health 

Resources and Services Administration, 

Parklawn Building, Rm 8C–103, 5600 

Fishers Lane, Rockville, MD 20857, Tel: 

301–443–2300, E-mail: 

policyanalysis@hrsa.gov. 

SUPPLEMENTARY INFORMATION: 

1. PDS Enrollment Availability 

The PDS prototype will be available 

April 30, 2007. An invitation to enroll 

practitioners in the prototype has been 

extended first to organizations that 

assisted HRSA with designing and 

pricing, which occurred between 2003 

and 2005. All NPDB registered entities 

have been invited to enroll their 

practitioners to meet a predetermined 

number for enrollees. Once this number 

is achieved, enrollment in the prototype 

will close. It is anticipated that the PDS 

prototype period will last approximately 

18 to 24 months before it is opened to 

all authorized Data Bank entities. 

2. User Fee Amount 

The NPDB is authorized by the Health 

Care Quality Improvement Act of 1986 

(the Act), Title IV of Public Law 99–660, 

as amended (42 U.S.C. 11101 et seq.). 

Section 427(b)(4) of the Act authorizes 

the establishment of fees for the costs of 

processing related to receiving and 

disclosing information. 


sroberts on PROD1PC70 with NOTICES
10228 Federal Register / Vol. 72, No. 44 / Wednesday, March 7, 2007 / Notices 

Final regulations at 45 CFR part 60 set 

forth these criteria and procedures for 

information to be reported to and 

disclosed by the NPDB. Section 60.3 of 

these regulations defines the terms used 

in this announcement. 

In determining any changes in the 

amount of the user fee, the Department 

uses the criteria set forth in section 

60.12(b) of the regulations. The 

Department must recover the full costs 

of operating the Data Bank through user 

fees. Paragraph (b) of the regulations 

states: 

‘‘The amount of each fee will be 

determined based on the following 

criteria: 

a. Use of electronic data processing 

equipment to obtain information—the 

actual cost for the service, including 

computer search time, runs, printouts, 

and time of computer programmers and 

operators, or other employees, 

b. Photocopying or other forms of 

reproduction, such as magnetic tapes—

actual cost of the operator’s time, plus 

the cost of the machine time and the 

materials used, 

c. Postage—actual cost, and 

d. Sending information by special 

methods requested by the applicant, 

such as express mail or electronic 

transfer—the actual cost of the special 

service.’’

An annual subscription fee of $3.25 

per practitioner will be charged upon 

enrollment. This fee includes the cost of 

an initial query, which automatically 

occurs when a practitioner is first 

enrolled, and all reports received on the 

enrolled practitioner over the course of 

the subscription period of 1 year. The 

fee was determined through economic 

analysis of the average annual rate of 

queries performed by health care 

entities in relationship to the current 

query fee that is based on the actual cost 

for services. The Department will accept 

payment for the subscription fee from 

entities via credit card or electronic 

funds transfer. When the prototype 

period concludes, the Department may 

change the subscription fee. Any 

changes will be announced through 

notice in the Federal Register. 

The periodic query fee remains at 

$4.75 per name. The practitioner selfquery fee remains at $8.00. Currently 

when a periodic query is on one or more 

physicians, dentists or other health care 

practitioners, the appropriate fee will be 

$4.75 multiplied by the number of 

individuals about whom the 

information is requested. Similarly, 

when a PDS prototype participating 

entity enrolls one or more physicians, 

dentists or other health care 

practitioners, the appropriate fee will be 

$3.25 multiplied by the number of 

individuals whom are enrolled. An 

individual practitioner may not enroll 

in PDS. For examples, see the tables 

below. 

Periodic query method 

Fee per 

name in 

query 

Examples 

Entity query (via) internet with electronic payment ....................................................................................... $4.75 10 names in query. 

10 x $4.75 = $47.50. 

Practitioner Self-query ................................................................................................................................... 8.00 One self-query = 

$8.00. 

Proactive disclosure service (PDS) query method 

Fee per 

name enrolled Examples 

Entity query (via) internet with electronic payment ....................................................................................... $3.25 10 names in query. 

10 x $3.25 = $32.50. 

Dated: March 1, 2007. 

Elizabeth M. Duke, 

Administrator. 

[FR Doc. E7–3974 Filed 3–6–07; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Government-Owned Inventions; 

Availability for Licensing 

AGENCY: National Institutes of Health, 

Public Health Service, HHS. 

ACTION: Notice. 

SUMMARY: The inventions listed below 

are owned by an agency of the U.S. 

Government and are available for 

licensing in the U.S. in accordance with 

35 U.S.C. 207 to achieve expeditious 

commercialization of results of 

federally-funded research and 

development. Foreign patent 

applications are filed on selected 

inventions to extend market coverage 

for companies and may also be available 

for licensing. 

ADDRESSES: Licensing information and 

copies of the U.S. patent applications 

listed below may be obtained by writing 

to the indicated licensing contact at the 

Office of Technology Transfer, National 

Institutes of Health, 6011 Executive 

Boulevard, Suite 325, Rockville, 

Maryland 20852–3804; telephone: 301/ 

496–7057; fax: 301/402–0220. A signed 

Confidential Disclosure Agreement will 

be required to receive copies of the 

patent applications. 

Novel System for HIV–1 Vaccine 

Development 

Description of Technology: The 

available technologies describe specific 

immunogenic peptides, peptide 

modifications and methods for 

identifying additional immunogens 

against HIV–1 surface proteins, gp120 

and gp41. Additionally, detailed 

methods for use of the described 

immunogenic peptides in the 

development of vaccines and 

diagnostics for HIV–1 are disclosed. The 

current technologies further include a 

comprehensive system for immunogen 

design, comprising in silico design 

coupled to feedback from X-ray 

crystallography, antigenic analysis, and 

immunization. 

The described methodology 

demonstrates how to transplant a given 

HIV–1 epitope recognized by broadly 

neutralizing antibodies into an 

appropriate scaffold, while preserving 

its structure and antigenicity. 

Conservation of the three dimensional 

structure may lead to the generation of 

antibodies with broadly neutralizing 

characteristics, similar to the template 

antibody. Such epitope-transplant 

scaffolds may serve as valuable 

diagnostics to identify specific serum 

reactivity against the target HIV–1 

epitopes. The subject scaffolding 

technology may be applied to any virus 

for which a broadly neutralizing 


sroberts on PROD1PC70 with NOTICES